Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mason, D.
Right arrow Articles by Zola, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, D.
Right arrow Articles by Zola, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 9, 1095-1098, September 2001
© 2001 Japanese Society for Immunology

SHORT REVIEW ARTICLE

CD antigens 2001

David Mason, Pascale André, Armand Bensussan, Chris Buckley, Curt Civin, Edward Clark, Masja de Haas, Sanna Goyert, Martin Hadam, Derek Hart, Václav Horejsí, Stefan Meuer, James Morrissey, Reinhard Schwartz-Albiez, Stephen Shaw, David Simmons, Mariagrazia Uguccioni, Ellen van der Schoot, Eric Vivier and Heddy Zola

The tradition of HLDA Workshops

The process of categorizing the antigenic molecules and epitopes associated with human white cells, via the collaborative study of mAb, dates back to the early 1980s, when the first HLDA (Human Leukocyte Differentiation Antigen) Workshop was held in Paris. This initial meeting listed only 15 agreed molecular entities, but it created an internationally agreed basis for the nomenclature of leukocyte molecules (the CD scheme), and also provided a forum for reporting studies on their function and practical relevance. A further six HLDA meetings have been held since the first Paris meeting. The most recent of these (`HLDA7') took place last year in Harrogate, UK and . . . [Full Text of this Article]

The aims and approaches of the 7th HLDA Workshop

The limitations of `blind' antibody screening
Selection of antibodies
New Workshop Sections
The yield of new CD specificities in the 7th HLDA Workshop

The 8th Workshop

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?